| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000016761 |
| Receipt No. | R000019269 |
| Official scientific title of the study | Skin test and flow cytometry in healthy volunteers to establish the method for determining causative drug of perioperative anaphylaxis: A preliminary study |
| Date of disclosure of the study information | 2015/03/10 |
| Last modified on | 2017/03/14 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | Skin test and flow cytometry in healthy volunteers to establish the method for determining causative drug of perioperative anaphylaxis: A preliminary study | |
| Title of the study (Brief title) | Skin test and flow cytometry in healthy volunteers | |
| Region |
|
|
| Condition | |||
| Condition | Anaphylaxis | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Although skin test has been widely used for identifying causative drug of anaphylaxis, it has some disadvantages including a risk of recurrent anaphylaxis and pain. The purpose this study is to establish an ideal tool for determing causative drug of perioperative anaphylaxis. For this purpose, we will focus on basophil activate test (BAT) with flow cytometry as an alternative to skin test. We will seek the maximum concentration not to see pseudo-positive reaction in healthy volunteers. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Seeking the optimum concentration of drugs for skin test and BAT |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Histamin as a positive control
Normal saline as a negative control Suspected drugs including sugamamdex and cephazolin |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) A volunteer who is 20 years or older
2) Avolunteer whose written consent has been obtained regarding participation in this study |
|||
| Key exclusion criteria | 1)A pregnant woman /A patient who has a possibility of pregnancy
2)A volunteer taking beta blocker 3)A volunteer taking steroid 4)A volunteer with past history of perioperative anaphylaxis 5)A volunteer to whom a doctor judged inappropriate for participating in this study |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Shigeru SAITO |
| Organization | Gunma University Hospital |
| Division name | Department of Anesthesiology |
| Address | 3-39-15 Showa-machi, Maebashi , Gunma, Japan 371-8511 |
| TEL | 027-220-8454 |
| shigerus@gunma-u.ac.jp | |
| Public contact | |
| Name of contact person | Tomonori TAKAZAWA |
| Organization | Gunma University Hospital |
| Division name | Department of Anesthiology |
| Address | 3-39-15 Showa-machi, Maebashi , Gunma, Japan 371-8511 |
| TEL | 027-220-8454 |
| Homepage URL | |
| takazawt@gunma-u.ac.jp | |
| Sponsor | |
| Institute | Gunma University Hospital, Department of Anesthesiology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Society for the Promotion of Science |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | To estimate the optimum concentration of the perioperative agent for a skin test and BAT |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000019269 |